🔎 Trials Near Me

Pradžia › Miastenija gravis › Pennsylvania

Miastenija gravis klinikiniai tyrimai Pennsylvania

6 tyrimai dėl Miastenija gravis ieško dalyvių vietose Pennsylvania.

Miestai Pennsylvania

Oficialus tyrimo tekstas (anglų kalba)

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)

  • The Childrens Hospital of Philadelphia, Philadelphia
Renkami dalyviai2 fazė
Amžius nuo 2 iki 17 · Visoms lytims · Atnaujinta 2026-09-01 · NCT06987539

A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis

  • Penn State Milton S Hershey Medical Ctr, Hershey
  • Childrens Hospital Of Philadelphia, Philadelphia
Renkami dalyviai2/3 fazė
Amžius nuo 2 iki 17 · Visoms lytims · Atnaujinta 2026-07-31 · NCT05265273

KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

  • Thomas Jefferson University Hospital, Philadelphia
Renkami dalyviai2/3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-07-29 · NCT06193889

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

  • Temple University Hospital, Philadelphia
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-02-25 · NCT06626919

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

  • Clinical Trial Site, Philadelphia
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-02-18 · NCT04202341

The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis

  • Thomas Jefferson University, Philadelphia
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-04-11 · NCT05564936

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.